Developing and Testing an Integrated mHealth Learning Program for Gynecological Cancer

Launched by CHANG GUNG MEMORIAL HOSPITAL · Aug 13, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on creating and testing a new mobile health learning program designed specifically for women with gynecological cancer, particularly those diagnosed with ovarian cancer that is at Stage 3 or below. The program aims to help these women by combining educational tools and a user-friendly smartphone app that will provide valuable information and support throughout their cancer treatment journey. The development of this program involves active participation from both the women with cancer and medical experts to ensure it meets their needs effectively.

To be eligible for this trial, participants should be women aged 20 to 70 who have been diagnosed with ovarian cancer and are currently undergoing treatment, such as surgery or chemotherapy. They must also be able to use a smartphone or tablet and communicate in Mandarin or Taiwanese. Participants can expect to contribute to the creation of a helpful resource while gaining access to information that may assist in their treatment and recovery. It’s important to note that women with a history of other cancers or certain mental health conditions are not eligible for this study.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Women definitively or suspected to be diagnosed with ovarian cancer, with the cancer staged at Stage 3 or below.
• • 2. Women receiving surgery, chemotherapy, or immunotherapy at the recruiting hospital.
• • 3.20 to 70 years old. 4.Possesses and is able to use an internet-enabled mobile device (such as a smartphone or tablet).
• • 5.Able to clearly communicate and read/write in Mandarin or Taiwanese. 6.Agrees to participate in the study and signs the informed consent form.
• Exclusion Criteria:
• • 1. History of other malignant tumors.
• • 2. Intellectual disability or mental disorders.